The landscape of dementia analysis has advanced dramatically with the appearance of subtle biomarkers, including amyloid PET scans, tau imaging, and blood-centered assessments which will detect Alzheimer's pathology several years just before signs emerge. Though these technological advancements depict impressive progress in understanding neurodegenerative health conditions, they have ... https://georgel429hlw7.bloggactivo.com/profile